Analysts Offer Insights on Healthcare Companies: Aerie Pharma (NASDAQ: AERI), UnitedHealth (NYSE: UNH) and Medtronic (NYSE: MDT)

By Carrie Williams

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Aerie Pharma (NASDAQ: AERI), UnitedHealth (NYSE: UNH) and Medtronic (NYSE: MDT).

Aerie Pharma (NASDAQ: AERI)

Stifel Nicolaus analyst Annabel Samimy reiterated a Buy rating on Aerie Pharma (NASDAQ: AERI) on May 24 and set a price target of $65. The company’s shares closed yesterday at $55.90, close to its 52-week high of $59.50.

According to TipRanks.com, Samimy is a 4-star analyst with an average return of 5.3% and a 53.5% success rate. Samimy covers the Healthcare sector, focusing on stocks such as Strongbridge Biopharma Plc, Corcept Therapeutics Inc, and Supernus Pharmaceuticals.

Currently, the analyst consensus on Aerie Pharma is Strong Buy and the average price target is $67.22, representing a 20.3% upside.

In a report issued on May 15, Aegis Capital also reiterated a Buy rating on the stock with a $63 price target.
UnitedHealth (NYSE: UNH)

In a report issued on May 24, Thomas Carroll from Stifel Nicolaus reiterated a Buy rating on UnitedHealth (NYSE: UNH), with a price target of $185. The company’s shares closed yesterday at $177.50, close to its 52-week high of $178.89.

According to TipRanks.com, Carroll is a 5-star analyst with an average return of 24.1% and a 80.0% success rate. Carroll covers the Healthcare sector, focusing on stocks such as WellCare Health Plans, Tivity Health Inc, and Molina Healthcare.

Currently, the analyst consensus on UnitedHealth is Strong Buy and the average price target is $190.25, representing a 7.2% upside.

In a report issued on May 17, Leerink Swann also maintained a Buy rating on the stock.
Medtronic (NYSE: MDT)

In a report issued on May 25, Rick Wise from Stifel Nicolaus reiterated a Hold rating on Medtronic (NYSE: MDT), with a price target of $91. The company’s shares closed yesterday at $85.09.

According to TipRanks.com, Wise is a 4-star analyst with an average return of 8.1% and a 63.9% success rate. Wise covers the Healthcare sector, focusing on stocks such as Corindus Vascular Robotics, Trivascular Technologies, and Obalon Therapeutics Inc.

Currently, the analyst consensus on Medtronic is Moderate Buy and the average price target is $91.40, representing a 7.4% upside.

In a report issued on May 16, Goldman Sachs also initiated coverage with a Hold rating on the stock with a $87 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.